Understanding the Knowledge Gaps in T1D for Better Care
Discover the crucial knowledge gaps in T1D care outlined by the Endocrine Society.Unlock the path to better understanding T1D.
Decoding the Endocrine Society Statement on Type 1 Diabetes
Unraveling the Endocrine Society statement on Type 1 Diabetes for insights on advances in T1D research.
Marvel’s New Superhero Omnya and Her Type 1 Diabetes
Marvel has introduced a new champion named Omnya, whose daily reality involves dealing with type 1 diabetes symptoms. She transforms into Dyasonic to protect others from her arch-enemy, D’Spayre, while also spotlighting the challenges real individuals face in managing this autoimmune condition. Her story is more than just a comic plot; it calls attention to…
Playing Sports with Type 1 Diabetes – Here’s your Tips!
Living with type 1 diabetes ain’t necessarily mean bidding sports adieu. Right sports medicine coupled with an optimal exercise plan lets diabetics partake in physical activities. Learning the balance game between insulin, nutrition intake, workouts, and blood sugar control is of utmost concern for maintaining steady sugar levels during sports. In this blog post, we…
Navigating Life with Type 1 Diabetes: A Comprehensive Guide to Effective Management
Type 1 diabetes (t1d) is a chronic condition that occurs when the body’s immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. Managing type 1 diabetes requires a vigilant and comprehensive approach to maintain blood glucose levels within a target range, prevent complications, and enhance overall well-being. Here’s a comprehensive guide for…
Fast-Acting Insulin Aspart Comparison in Closed Loop Delivery System for Type 1 Diabetes
Previously Published on Endocrinologyadvisor.com – Findings from a 17-week, randomized, open-label, crossover study comparing the efficacy of fast-acting insulin aspart (faster aspart) with standard insulin aspart (IAsp) delivered by an automated closed-loop system in adults with type 1 diabetes(T1D) showed faster aspart demonstrated greater glucose time in range (TIR) compared with IAsp (82.3% [78.5, 83.7]…
New Study: Ketogenic Lifestyle is Beneficial for People with T1D
Previously published on Diabetestimes.co.uk – People with type 1 diabetes can benefit from a ketogenic lifestyle just as much as those without the condition. This new study was reported in the journal Endocrinology, Diabetes and Obesity. The feasibility of exercising over five days while fasting, in those with and without t1d mellitus, tested during the study. Academic, Ian Lake, analyzed…
NexImmune Explores AIM Direct Injection Technology in T1D
Previously Published on Biospace.com – Neximmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced a collaboration with Yale University’s Department of Immunobiology. The collaboration will focus on the use of NexImmune’s direct injection, artificial antigen…